Boston Scientific (BSX) Other Accumulated Expenses (2009 - 2026)

Boston Scientific has disclosed Other Accumulated Expenses across 18 years of filings, most recently posting $732.0 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 23.11% year-over-year to $732.0 million; the TTM figure through Jun 2026 stood at $732.0 million (down 23.11% YoY), while the FY2025 annual figure was $795.0 million, down 10.37% from the prior year.
• Other Accumulated Expenses came in at $732.0 million for Q2 2026 at Boston Scientific, down from $875.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.0 billion in Q1 2022 to a low of $732.0 million in Q2 2026.
• Average Other Accumulated Expenses over 5 years is $848.2 million, with a median of $844.5 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses jumped 46.67% in 2022 and fell 23.89% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $761.0 million in 2022, then gained by 6.96% to $814.0 million in 2023, then advanced by 8.97% to $887.0 million in 2024, then retreated by 10.37% to $795.0 million in 2025, then dropped by 7.92% to $732.0 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $732.0 million in Q2 2026, $875.0 million in Q1 2026, and $795.0 million in Q4 2025.